Smart binding. Strong protection.
We operate at the intersection between in silico modeling, synthetic biology and genetic engineering to develop the next generation of medical devices for women’s health
What makes us different
We are not a biotech that later “adds AI”.
We are not a software company that later “adds biology”.
We were built as an integrated stack from day one.
Computation informs molecular engineering from the start.
Regulatory endpoints are not an afterthought. They are inflection points that shape optimization.
Meet the team
We believe innovation is born at the intersection of minds.
A biologist sees a biomolecule. A physicist sees forces and structures. A mathematician sees patterns. A data scientist sees relationships. Where these perspectives meet, complexity becomes clarity. Ideas gain depth. Solutions gain strength. Academia discovers knowledge. We harness it creating innovative products.
Our diversity is not a coincidence but it is our strategy.
Different disciplines. One shared curiosity.
One ambition: transforming scientific understanding into breakthroughs that matter.
.png)
MATTEO BARONI, Ph.D
CEO
Biomedical Scientist, former Venture Capital analyst, and neuro-oncology start-up co-founder.
.png)
RUDY IPPODRINO, Ph.D
CSO - BIOTECH
Cofounded 3 startups, 12 Biotech and nanotech patents, over 100 products developed.
.png)
FRANCESCA PARON
SCIENTIST
Experienced molecular biologist with strong expertise in translational science and degenerative diseases.
.png)
COLLEEN FARRELLY
CHIEF MATHEMATICIAN
Data analysis in ML, networks, computational dynamics and neuroscience research.
.png)
SID. DESHPANDE
CTO
Extensive experience across Natural Language Processing, Advanced AI, and Data Science.
.png)
LUKE ROBINSON, Ph.D
CSO - DATA SCIENCE
Cofounded 11 AI-based startups with Post Urban Ventures, PhD in Quantum Computing.
.png)
LAWRENCE BANKS, Ph.D
SCIENTIFIC ADVISOR
Director-General of ICGEB, expert on HPV oncogenes, translational virology and cancer biology.
.png)
ELEONORA DA POZZO, Ph.D
SCIENTIFIC ADVISOR
Translational pharma researcher in drug development, molecular targeting, and anti-HPV therapies.
.png)
REINHARD KIRNBAUER, MD
SCIENTIFIC ADVISOR
Pioneer of HPV vaccine science, developer of VLP technology, leader in viral oncology.
Different roots. Global impact.
International by Nature, Global by Impact
We are an internationally diverse team by design. International scientists drive our scientific vision. UK-based machine learning experts power our computational edge.
US scientists specialized in deep learning expand our technological frontier.
Our diversity goes beyond geography. It spans disciplines, methodologies, and ways of thinking. This international and cross-competence heterogeneity is our strength, enabling a truly global footprint from day one.
Get in Touch
Interested in partnering with us or learning more about our platform?
Reach out. We’re always open to meaningful collaborations.